Morikawa, K., Tanaka, H., Itani, H., Takata, S., Watanabe, S., Kishi, K., . . . Seki, N. (2020). Hypothesis generative head-to-head study comparing efficacy of afatinib and osimertinib based on immunological biomarkers in Japanese NSCLC patients with EGFR mutations (Heat on Beat study). Ther Adv Med Oncol.
Chicago-стиль цитированияMorikawa, Kei, et al. "Hypothesis Generative Head-to-head Study Comparing Efficacy of Afatinib and Osimertinib Based On Immunological Biomarkers in Japanese NSCLC Patients With EGFR Mutations (Heat On Beat Study)." Ther Adv Med Oncol 2020.
MLA-цитированиеMorikawa, Kei, et al. "Hypothesis Generative Head-to-head Study Comparing Efficacy of Afatinib and Osimertinib Based On Immunological Biomarkers in Japanese NSCLC Patients With EGFR Mutations (Heat On Beat Study)." Ther Adv Med Oncol 2020.